Protective Effect of Curcumin on Pulmonary and Cardiovascular Effects Induced by Repeated Exposure to Diesel Exhaust Particles in Mice by Nemmar, Abderrahim et al.
Protective Effect of Curcumin on Pulmonary and
Cardiovascular Effects Induced by Repeated Exposure to
Diesel Exhaust Particles in Mice
Abderrahim Nemmar
1*, Deepa Subramaniyan
1, Badreldin H. Ali
2
1Department of Physiology, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates, 2Department of Pharmacology and
Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Al-Khod, Sultanate of Oman
Abstract
Particulate air pollution has been associated with increased risk of cardiopulmonary diseases. However, the underlying
mechanisms are not fully understood. We have previously demonstrated that single dose exposure to diesel exhaust
particle (DEP) causes lung inflammation and peripheral thrombotic events. Here, we exposed mice with repeated doses of
DEP (15mg/animal) every 2
nd day for 6 days (a total of 4 exposures), and measured several cardiopulmonary endpoints 48 h
after the end of the treatments. Moreover, the potential protective effect of curcumin (the yellow pigment isolated from
turmeric) on DEP-induced cardiopulmonary toxicity was assessed. DEP exposure increased macrophage and neutrophil
numbers, tumor necrosis factor a (TNF a) in the bronchoalveolar lavage (BAL) fluid, and enhanced airway resistance to
methacoline measured invasively using Flexivent. DEP also significantly increased plasma C-reactive protein (CRP) and
TNF a concentrations, systolic blood pressure (SBP) as well as the pial arteriolar thrombosis. It also significantly enhanced
the plasma D-dimer and plasminogen activator inhibitor-1 (PAI-1). Pretreatment with curcumin by oral gavage (45 mg/kg)
1h before exposure to DEP significantly prevented the influx of inflammatory cells and the increase of TNF a in BAL, and the
increased airway resistance caused by DEP. Likewise, curcumin prevented the increase of SBP, CRP, TNF a, D-dimer and PAI-
1. The thrombosis was partially but significantly mitigated. In conclusion, repeated exposure to DEP induced lung and
systemic inflammation characterized by TNFa release, increased SBP, and accelerated coagulation. Our findings indicate that
curcumin is a potent anti-inflammatory agent that prevents the release of TNFa and protects against the pulmonary and
cardiovascular effects of DEP.
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Introduction
A number of epidemiological studies reported strong and
consistent associations between exposure particulate air pollution
and increase of respiratory and cardiovascular morbidity and
mortality [1,2]. In this context, epidemiological time-series studies
have identified an association between daily changes in concen-
tration of ambient air pollution and daily number of deaths and
hospitalizations, particularly from cardiovascular disease and
following relatively short time lags after exposure peaks [1,2]. It
has been suggested that traffic-derived particles, of which diesel
exhaust particles (DEP) are major contributor, are the most toxic
component [1,2]. Moreover, the ambient level of black carbon
particles, used as a tracer for traffic pollution, has been consistently
associated with a variety of adverse health outcomes [1,2].
A number of possible mechanisms have been suggested to
explain these effects, including direct effects of particles that
translocated into the systemic circulation, disturbances of the
cardiac autonomic nervous system, and pulmonary and systemic
oxidative stress and inflammatory responses that trigger endothe-
lial dysfunction, atherosclerosis, and coagulation [1,3]. However,
the exact mechanistic pathways are still not fully understood.
Human studies have previously demonstrated that controlled
exposure to DEP results in endothelial dysfunction, impaired
endogenous fibrinolysis, and increased thrombus formation in
both healthy human subjects and in patients with stable coronary
heart disease [4,5]. Similarly, DEP impairs endothelium-depen-
dent vasodilatation in animal studies both in vivo and ex vivo [2]. We
have recently demonstrated that single dose pulmonary exposure
to DEP (up to 24 h) induces pulmonary and systemic inflamma-
tion and the occurrence of thrombotic events in the femoral vein
and artery of hamsters and cerebral microvessels of mice [6–8].
However, the effect repeated exposure of DEP on airway
inflammation and resistance and pial arteriole thrombosis and
markers of coagulation has not been reported so far.
Curcumin is the major yellow pigment in turmeric (the ground
rhizome of Curcuma longa Linn), which is widely used as a spice and
coloring agent in several foods, as well as cosmetics and drugs
[9,10]. Recently, curcumin has been identified as an inhibitor of
oxidant-, cytokine-, and cigarette smoke-induced NF-kB activation
in human lung epithelial cell lines [11]. Indeed, oral curcumin
administration has been reported to inhibit bleomycin-induced
pulmonary fibrosis in rats [12] and cigarette smoke-induced lung
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knowledge no study, to date, has addressed the effect of curcumin
on the pulmonary and cardiovascular effects of DEP.
Consequently, in the present study, we have assessed the effect
of repeated exposure to DEP (15 mg/animal) 48 h after the last of
four exposures to DEP performed every second day on a
comprehensive set of indices of respiratory endpoints including
pulmonary inflammation and airway resistance measured inva-
sively using forced oscillation as well as cardiovascular parameters,
including blood pressure, pial arterioles thrombosis and markers of
inflammation and fibrinolysis. Moreover, we assessed the possible
protective effect of curcumin on DEP-induced pulmonary and
cardiovascular events.
Materials and Methods
Ethics Statement
This project was reviewed and approved by the Institutional
Review Board of the United Arab Emirates University, Faculty of
Medicine and Health Sciences, and experiments were performed
in accordance with protocols approved by the Institutional Animal
Care and Research Advisory Committee.
Particles
Diesel exhaust particles (DEP; SRM 2975), obtained from the
National Institute of Standards and Technology (NIST, Gaithers-
burg, MD, USA), were suspended in sterile normal saline
(NaCl 0.9 %) containing Tween 80 (0.01 %). To minimize
aggregation, particle suspensions were always sonicated (Clifton
Ultrasonic Bath, Clifton, New Jersey, USA) for 15 min and
vortexed before their dilution and prior to intratracheal (i.t.)
administration. Control animals received normal saline containing
Tween 80 (0.01 %). We have previously [14] analyzed the size of
DEP used in the present study by transmission electron
microscopy, and found a substantial amount of ultrafine (nano)
sized of carbonaceous particle aggregates and larger particle
aggregates (, 1 mm in largest diameter). Geometric mean
aerodynamic diameter of 215unm generated from the same DEP
material have been previously reported [15].
Animals and treatments
Male TO mice (30–35 g, HsdOla:TO, Harlan, UK) were
housed in light (12-h light:12-h dark cycle) and temperature-
controlled (2261uC) rooms. They had free access to commercial
laboratory chow and were provided tap water ad libitum.
Mice were anesthetized with sodium pentobarbital (60 mg/kg,
i.p.), placed supine with extended neck on an angled board. A
Becton Dickinson 24 Gauge cannula was inserted via the mouth
into the trachea. Either the DEP suspensions (15 mg/mouse) or
saline-only were instilled intratrachealy (i.t.) (50 ml) via a sterile
syringe and followed by an air bolus of 50 ml every other day. DEP
(15 mg/mouse) or saline were i.t. administered on days 0, 2, 4, 6,
and 48 hours after the last exposure to DEP, various pulmonary
and cardiovascular endpoints were measured (figure 1). Eight mice
were included in each group.
Systolic blood pressure (SBP) measurement
48 hours after the last exposure to DEP, the systolic BP (SBP)
was measured using a computerized noninvasive tail-cuff manom-
etry system (ADInstrument, Colorado Springs, USA). To avoid
procedure-induced anxiety, mice were trained for 5 consecutive
days before the experimental procedure [16].
Blood collection and analysis of bronchoalveolar lavage
(BAL) fluid
48 hours after the last i.t. administration of either saline or DEP,
the animals were anesthetized, as described above, and blood was
drawn from the inferior vena cava in EDTA (4 %). A sample was
used for platelets and white blood cells (WBC) counts using an
ABX VET ABC HEMATOLOGY ANALYZER with a mouse card (ABX
Diagnostics, Montpellier, France). The remaining blood was
centrifuged at 4uC for 15 min at 900 g and the plasma samples
were stored at –80uC until further analysis.
Mice were then killed with an overdose of sodium pentobarbital.
The trachea was cannulated and lungs were lavaged three times
with 0.7 ml (a total volume of 2.1 ml) of sterile NaCl 0.9 %. The
recovered fluid aliquots were pooled. No difference in the volume
of collected fluid was observed between the different groups. BAL
fluid was centrifuged (1,000 g 610 min, 4uC). Cells were counted
after resuspension of the pellets and the differentials were
microscopically performed on cytocentrifuge preparations fixed
in methanol and stained with Diff Quick (Dade, Brussels,
Belgium). The supernatant was stored at 280 uC until further
analysis.
In the BAL fluid, the concentrations of tumor necrosis factor a
and IL-6 were determined using ELISA Kits (R & D systems,
Minneapolis, MN).
Airway reactivity to methacholine
In separate animals, airway hyperreactivity responses were
measured using a forced oscillation technique (FlexiVent,
SCIREQ, Montreal, Canada). Airway resistance (R) was assessed
after increasing exposures to methacholine. Mice were anesthe-
tized with an intraperitoneal injection of pentobarbital (70 mg/
kg). The trachea was exposed, and into it, an 18-gauge metal
needle was inserted. Mice were connected to a computer-
controlled small animal ventilator and quasi-sinusoidally ventilated
with a tidal volume of 10 ml/kg at a frequency of 150 breaths/
min and a positive end-expiratory pressure of 2 cm H2Ot o
achieve a mean lung volume close to that during spontaneous
breathing. After measurement of a baseline, each mouse was
challenged with methacholine aerosol, generated with an in-line
nebulizer and administered directly through the ventilator for 5s,
with increasing concentrations (0, 0.625, 1.25, 2.5, 5, and 10 mg/
ml). Airway resistance (R) was measured using a "snapshot"
protocol each 20 s for 2 min. The mean of these six values was
used for each methacholine concentration, unless the coefficient of
determination of a measurement was smaller than 0.95. For each
mouse, R was plotted against methacholine concentration (from 0
to 10 mg/ml) [17].
Determination of IL-6, TNFa, C-reactive protein (CRP), D-
dimer and plasminogen activator inhibitor-1 (PAI-1)
concentrations in plasma
The concentrations of mouse IL-6, TNF a (R & D systems,
Minneapolis, MN, USA), PAI-1 (Molecular Innovation, South-
field, MI, USA), D-dimer (Uscn Life Science Inc, Wuhan, China)
and CRP (Uscn Life Science Inc, Wuhan, China) were determined
using ELISA Kits.
Experimental pial cerebral arterioles thrombosis model
In a separate experiment, in vivo pial arterioles thrombogenesis
was assessed 48 hours after the last i.t. instillation of either DEP or
saline, according to a previously described technique [7,8]. Briefly,
the trachea was intubated after induction of anesthesia with
urethane (1 mg/g body weight, i.p.), and a 2F venous catheter
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administration of fluorescein (Sigma, St. Louis, MO, USA). After
that, a craniotomy was first performed on the left side, using a
microdrill, and the dura was stripped open. Only untraumatized
preparations were used, and those showing trauma to either
microvessels or underlying brain tissue were discarded. The
animals were then placed on the stage of a fluorescence
microscope (Olympus, Melville, NY, USA) attached to a camera
and DVD recorder. A heating mat was placed under the mice and
body temperature was raised to 37uC, as monitored by a rectal
thermoprobe connected to a temperature reader (Physitemp
Instruments, NJ, USA). The cranial preparation was moistened
continuously with artificial cerebrospinal fluid of the following
composition (mM): NaCl 124, KCl 5, NaH2PO4 3, CaCl2 2.5,
MgSO4 4, NaHCO3 23 and glucose 10, pH 7.3–7.4. A field
containing arterioles 15–20 mm in diameter was chosen. Such a
field was taped prior to and during the photochemical insult,
which was carried out by injecting fluorescein (0.1 ml/mouse of
5 % solution) via the jugular vein, which was allowed to circulate
for 30–40 sec. The cranial preparation was then exposed to
stabilized mercury light. The combination produces endothelium
injury of the arterioles. This, in turn, causes platelets to adhere at
the site of endothelial damage and then aggregate. Platelet
aggregates and thrombus formation grow in size until complete
vascular occlusion. The time from the photochemical injury until
full vascular occlusion (time to flow stop) in arterioles were
measured in seconds. At the end of the experiments, the animals
were euthanized by an overdose of urethane.
Effect of curcumin pretreatment on pulmonary and
systemic parameters
Curcumin (also named diferuloylmethane) [(E, E)-1,7-bis(4-
hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, Sigma] 45
mg/kg [18] was suspended in 200 ml of vehicle (0.5 % methylcel-
lulose; Sigma) or 200 ml of vehicle alone was administrated by oral
gavage to mice [18] 1 h before each i.t. saline or DEP, and all the
parameters described above were evaluated (figure 1). The dose of
curcumin administered was chosen to approximate, on a weight
per weight basis, curcumin doses that have been well tolerated in
humans in previous studies [18].
Statistics
Data were analyzed with GraphPad Prism Version 4.01 for
Windows software (Graphpad Software Inc., San Diego, USA)
and expressed as means 6SEM. Data were tested for normal
distribution using the Kolmogorov–Smirnov test. After that, one-
way analysis of variance (ANOVA), followed by Bonferroni post-hoc
test, was used to determine differences between the different
groups. P values less than 0.05 were considered significant.
Results
Cell composition and number in BAL fluid
Depending on the i.t. treatment performed, the cells found in
BAL were primarily macrophages and PMN (figure 2A–B).
Lymphocytes were not found in control mice BAL. No other cells
were observed microscopically.
Repeated i.t. administration of DEP caused a marked and
significant increase in macrophages. Similarly, repeated exposure
to DEP caused a significant increase in PMN numbers. TNFa
concentrations (but not IL-6) were also increased following the i.t.
instillation of DEP in mice. Curcumin pretreatment alone did not
affect the cell numbers or the measured cytokines. However,
curcumin pretreatment significantly prevented the influx of
inflammatory cells and the increase of TNFa concentrations in
BAL.
Airway hyper-reactivity to methacholine
Figure 3 shows airway resistance to increasing concentrations of
methacholine after repeated exposure to either saline or DEP with
or without curcumin pretreatment. Repeated exposure to DEP
caused a significant and dose-dependent increase in the airway
resistance compared with the saline-treated group. No statistical
differences were observed between the groups treated with saline
or curcumin+saline. Interestingly, curcumin pretreatment com-
pletely prevented DEP-induced enhancement of airway resistance
after increasing concentrations of methacholine.
CRP, TNF a and IL-6 concentrations in plasma
Repeated exposure to DEP caused systemic inflammation
evidenced by a significant rise in CRP (figure 4A) and TNF a
(figure 4B) (but not IL-6, figure 4C) concentrations in plasma
compared with saline-treated group. Curcumin pretreatment
alone did not significantly affect the measured inflammatory
markers. Pretreatment of mice with curcumin significantly
reversed the increases in CRP (figure 4A) and TNFa (figure 4B)
caused by the repeated exposure to DEP.
Systolic blood pressure (SBP)
Figure 5 illustrates the effect of repeated i.t. administration of
DEP on SBP in mice. Compared to that in the controls, repeated
exposure to DEP exhibited a significant increase in SBP. While
treatment with curcumin+saline did not affect SBP, curcumin
significantly prevented the increase of SBP induced by repeated i.t.
instillation of DEP.
Figure 1. Treatments and endpoints following the repeated intratracheal instillation (i.t.) of saline or diesel exhaust particles (DEP)
with or without curcumin pretreatment (given by oral gavage) in mice. SBP: systolic blood pressure; BAL: bronchoalveolar lavage.
doi:10.1371/journal.pone.0039554.g001
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thrombosis in pial arterioles
Platelet counts in blood were significantly decreased by repeated
exposure to DEP compared with control mice (figure 6A),
indicating the occurrence of platelet aggregation in vivo. Pretreat-
ment with curcumin did not affect the circulating platelet
numbers. However, curcumin pretreatment partially and signifi-
cantly prevented the decrease in platelet numbers caused by
repeated exposure to DEP (figure 6A).
In line with the results of platelet numbers, compared to control
group, repeated exposure to DEP induced a shortening of the
occlusion time in pial arterioles in a photochemically injured
vessel. Curcumin alone did not affect the thrombotic occlusion
time. In mice pretreated with curcumin, there was a partial and
significant abrogation in DEP-induced shortening of the occlusion
time in pial arterioles (Figure 6B).
D-dimer, PAI-1 and vWF plasma concentrations
Figure 7 illustrates the effect of repeated exposure to DEP on
the plasma concentration of D-dimer (figure 7A), PAI-1 (figure 7B)
and vWF (figure 7C). Compared to control group, repeated
exposure to DEP caused a significant increase in D-dimer.
Likewise the plasma concentrations of PAI-1 were significantly
increased by the repeated i.t. instillation of DEP. In contrast, the
concentrations of vWF in plasma were not significantly affected by
DEP. Curcumin alone did not affect the plasma D-dimer
concentration but it significantly prevented its increase caused
by repeated exposure to DEP. Similarly, pretreatment with
curcumin alone did not affect the plasma PAI-1 levels. However,
curcumin significantly inhibited the increase of PAI-1 induced by
DEP.
Discussion
The present work provides experimental evidence that repeated
exposure to DEP induces lung and systemic inflammation and
airway hyperreactivity, increases SBP, and accelerates coagulation.
TNF a production was increased both in BAL and plasma.
Interestingly, pretreatment with curcumin significantly prevented
the respiratory and cardiovascular effect and inhibited the release
of TNF a.
In the present study, we assessed the effect of repeated exposure
to DEP on respiratory and cardiovascular endpoints. This
approach is more relevant to human exposure scenarios than
single dose exposure. The dose used here is close to the range of
Figure 2. Number of macrophages (A) and polymorphonuclear neutrophils (PMN) (B), and tumor necrosis factor a (TNF a, C) and
interleukin-6 (IL-6, D ) concentrations in bronchoalveolar lavage, after repeated intratracheal instillation of saline or diesel exhaust
particles (DEP, 15 mg/animal) with or without curcumin pretreatment. Data are mean 6 SEM (n=8 in each group). Statistical analysis by
one-way analysis of variance (ANOVA), followed by Bonferroni multiple-range tests.
doi:10.1371/journal.pone.0039554.g002
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United States Environmental Protection Agency described a range
of maximal city PM10 concentrations between 26 and 534 mg/m
3
[20]. Numerous mega cities in the world have much greater levels
of PM10, with annual averages of 200 to 600 mg/m
3 and peak
concentrations frequently exceeding 1,000 mg/m
3 [21]. Using the
highest value in the United States and assuming a minute
ventilation of 6 l/min (,8.6 m
3 over 24 hours) for a healthy adult
at rest, the total dose of PM inhaled over 24 hours would be
4,614 mg [19]. Exposure of a human to a daily dose of 4,614 mgo f
PM would correspond to more than 35 mg of PM exposure for a
mouse (25 grams) with minute ventilation of 35–50 ml/min [19].
The dose we tested here (15 mg/mouse every 2
nd day) is lower
than the comparative human dose of635 mg/mouse/24 h report-
ed by Mutlu et al. [19]. However, one should take into account
that this estimation does not consider particles deposited per
surface area of the lung. Also, our study was performed on
particles of a nanometer to 1 micrometer diameter [14,15],
whereas the study of Mutlu et al.[19] used PM10. Therefore, the
dose of particles given in the present study in terms of reactive
surface area will be higher than that of available surface area of
PM10 reported previously [19]. Mice were exposed to DEP by i.t.
instillation because it provides more accurate dosing, given that
mice are nose breathers that filter most inhaled particles [22].
Our data show that repeated exposure to DEP causes a
significant inflammatory reaction in the lung characterized by an
increase of macrophages and neutrophils in BAL fluid. Similar
observations after single dose exposure to particles have been
reported in mice hamsters or in rats [19,23–26]. In humans, an
increase in the number of neutrophils and mast cell in bronchial
submucosa, as well as interleukin-8 and myeloperoxidase concen-
trations in bronchial lavage have been previously reported [27,28].
Along with inflammatory cell influx, we found a significant
increase in the concentration of TNFa in BAL fluid. This finding
Figure 3. Airway hyper-responsiveness. The airway resistance (R),
after increasing concentrations of methacholine (0–10 mg/ml), was
measured via the forced oscillation technique (FlexiVent) after repeated
intratracheal instillation of saline or diesel exhaust particles (DEP, 15 mg/
animal) with or without curcumin pretreatment. Data are mean 6SEM
(n=8 in each group). Statistical analysis by one-way analysis of variance
(ANOVA), followed by Bonferroni multiple-range tests. indicates
P,0.001 between DEP and saline groups for the same methacholine
concentration. D: indicates P,0.01 between DEP and curcumin+DEP
groups for the same methacholine concentration. DD:i n d i c a t e s
P,0.001 between DEP and curcumin+DEP groups for the same
methacholine concentration.
doi:10.1371/journal.pone.0039554.g003
Figure 4. C-reactive protein (CRP, A), tumor necrosis factor a
(TNF a, B) and interleukin-6 (IL-6, C) concentrations in plasma,
after repeated intratracheal instillation of saline or diesel
exhaust particles (DEP, 15 mg/animal) with or without curcumin
pretreatment. Data are mean6SEM (n=8 in each group). Statistical
analysis by one-way analysis of variance (ANOVA), followed by
Bonferroni multiple-range tests.
doi:10.1371/journal.pone.0039554.g004
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increase of TNFa by alveolar macrophages in particle-exposed
mice [25,29] and humans [30,31]. Although we did not find an
increase of IL-6 in BAL 48 h after the last exposure, this does not
necessarily exclude its release at earlier time point of exposure to
DEP. Indeed, we have recently shown that exposure to single dose
of DEP caused a significant increase of IL-6 at 18 h time point but
not at 4 or 24 h post-exposure [8,32]. Besides causing lung
inflammation, repeated exposure to DEP induced an increase in
airway resistance assessed by forced oscillation technique after
increasing concentration of metacholine. Interestingly, the baseline
of airway resistance in DEP exposed mice was higher compared to
that in control group. The airway resistance has further dose-
dependently increased following increasing dose of metacholine.
This effect can be ascribed to the inflammatory reaction taking
place in the airways, i.e. influx of inflammatory cells and release of
TNFa that caused the observed airway hyperreactivity. We have
recently demonstrated that single dose of DEP (30 mg/mouse)
caused a significant increase in airway resistance. However, the
baseline of airway resistance between control and DEP was not
affected. Furthermore, compared to their respective controls, the
extent of increase in airway resistance observed in the present
study is greater than that observed after exposure to single dose of
DEP [8]. A number of studies have found increased risks of
asthma outcomes in children and adults who live near roadways
with high traffic counts [33]. Evidence of airway inflammation has
been observed in healthy volunteers in multiple studies [34], and
increased airway hyper-responsiveness has been seen in asthmatic
subjects [33].
Although the precise mechanism leading to cardiovascular
morbidity and mortality caused by particles is still not fully
understood, several studies have shown that systemic inflammation
may be a key step in these pathological process through the release
of inflammatory mediators [1]. Our data show that repeated
exposure to DEP causes systemic inflammation. In fact, we found
a significant increase of CRP and TNFa in plasma. An increase of
plasma CRP has been recently reported in diabetic mice during
inflammation [35,36]. The absence of increase of plasma IL-6
48 hours after the last exposure to DEP in association with the
increase of CRP may appear contradictory given the requirement
for IL-6 to induce CRP expression [37]. This, however, does not
exclude the release of IL-6 at earlier time point, and suggests that
the kinetic of release of these two inflammatory markers is different
at least 48 hours after the last exposure to DEP. Additional studies
are required to clarify this point. Our findings are in line with
human studies that found that risk of cardiovascular events,
including myocardial infarction is associated with increased blood
levels of inflammatory cytokines such as TNF-a and its receptors,
adhesion molecules, and CRP [30,38,39].
We have recently demonstrated that single i.t. exposure to DEP
(30 mg/mouse) in healthy mice caused a decrease in SBP at 4 and
18 h post exposure [8]. This effect may be due to the dose of
particles administered in this study causing cardiac contractile
dysfunction [40]. Here, we show that lower doses of DEP (15 mg/
Figure 5. Systolic blood pressure, after repeated intratracheal
instillation of saline or diesel exhaust particles (DEP, 15 mg/
animal) with or without curcumin pretreatment. Data are
mean6SEM (n=8 in each group). Statistical analysis by one-way
analysis of variance (ANOVA), followed by Bonferroni multiple-range
tests.
doi:10.1371/journal.pone.0039554.g005
Figure 6. Circulating platelets numbers (A) and occlusion time
in pial arterioles (B), after repeated intratracheal instillation of
saline or diesel exhaust particles (DEP, 15 mg/animal) with or
without curcumin pretreatment. Data are mean6SEM (n=8 in each
group). Statistical analysis by one-way analysis of variance (ANOVA),
followed by Bonferroni multiple-range tests.
doi:10.1371/journal.pone.0039554.g006
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nd day for 6 days lead to an
increase of SBP which was significant 48 h after the last exposure.
A significant increase in SBP was even observed 48 h after the 2
nd
and 3
rd exposure to DEP (data not shown). Most of the studies
demonstrated that BP increases only a few days (lags 2 to 5) after
an elevation in ambient PM2.5 levels and/or following a longer
duration (2 to 30 days) of exposure [40]. Our observed increase of
SBP could be related to the increase TNFa and CRP leading
endothelial and/or smooth muscle dysfunction. Indeed, prolonged
PM2.5 exposures have proven capable of sensitizing the vascula-
ture to a variety of vasoactive mediators thus tipping vasomotor
balance towards vasoconstriction [40]. Our results are in
agreement with earlier findings which reported that prolonged
exposures to particulate air pollution caused an inflammatory
response (release of cytokines) within the systemic circulation.
Markers of oxidative stress were also increased [40,41]. These
responses probably played a causal role in the observed
impairment in endothelial cell function and vasomotor balance
[40,41]. Further studies have substantiated that PM2.5 can induce
arterial vascular dysfunction likely via systemic inflammation/
oxidative stress-dependent pathways [40,41].
In the present study, we have assessed the effect of DEP on
coagulation events by measuring a set of indices, i.e. thrombosis
assessment in pial arterioles in vivo, platelet numbers and
measurement of circulating PAI-1, soluble vWF and D-dimer.
Our data show that repeated exposure to DEP cause thrombotic
events in pial arterioles and a decrease of platelet numbers
suggestive of platelet aggregation that occurred in vivo. A decrease
of platelet number after exposure to particles has been reported
both in mice [7] and clinical studies [42]. As for SBP, this observed
prothrombotic effects can be ascribed the release of TNFa and
CRP. A positive correlation of CRP and coronary artery disease,
which could be explained by the atherogenic effects of continuing
inflammation has been previously described [43]. An association
between minor but persistent elevation of serum CRP concentra-
tion and future major cardiovascular events has also been shown
[44]. Elevated concentrations of proinflammatory cytokines such
as TNFa, and CRP play a significant role in the genesis of
atherosclerosis and in plaque instability [43]. We found a
significant increase of circulating PAI-1 following repeated
exposure to DEP. Raised concentrations of circulating PAI-1
have been recognized as an independent risk factor for the
development of ischemic cardiovascular events and have been
associated with inflammation and atherosclerosis [45,46]. A recent
study reported an increase in PAI-1 mRNA and protein
concentrations in lung and adipose tissue of mice treated with
concentrated ambient particulate matter or PM [29]. While the
concentrations of soluble vWF were not affected by repeated
exposure to DEP, plasma concentration of D-dimer, the primary
degradation product of cross-linked fibrin, was significantly
increased. This effect has, to the best of our knowledge, not been
reported before. Plasma concentrations of D-dimer have been
found to be significantly raised in several acute thrombotic
disorders [47,48]. There is a growing evidence that there may be
an association between elevated concentrations of D-dimer and
increased risk of future myocardial infarction [47,48]. However,
only few epidemiological studies have studied the association
between particulate air pollution and D-dimer concentrations
[39,49]. The results reported did not show a significant correlation
between concentration of PM and those of D-dimer [39,49].
Figure 7. Plasma concentrations of D-dimer (A), plasminogen
activator inhibitor 1 (PAI-1, B) and von Willebrand factor (vWF,
C), after repeated intratracheal instillation of saline or diesel
exhaust particles (DEP, 15 mg/animal) with or without curcumin
pretreatment. Data are mean06SEM (n=8 in each group). Statistical
analysis by one-way analysis of variance (ANOVA), followed by
Bonferroni multiple-range tests.
doi:10.1371/journal.pone.0039554.g007
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needed to clarify this point.
To our knowledge, no study, to date, has addressed the effect of
curcumin on the cardiovascular and pulmonary effects following
DEP exposure. Because of the observed inflammatory reaction
caused by DEP, mice were pretreated with curcumin. The latter is
reported to possess a numerous of beneficial activities, such as
antitumor, antioxidant, and antiinflammatory activities [9]. It has
been shown to interfere with the activities of NF-kB, cytochrome
P450, and b amyloid accumulation, production of inflammatory
cytokines, and the activity of p300 [18,50]. Human studies
indicate that curcumin is tolerated in large oral doses without
apparent toxicity [51]. The dose (45 mg/kg) used in the present
study was selected from previously published studies which has
been reported to correct cystic fibrosis defect in mice [18] and to
inhibit tumour growth in a NCI-H460 xenograft mouse model in
vivo [52]. This dose has been reported to correspond, on the basis
of mg/kg scaling, to doses of commercially available curcumin
products that are routinely consumed [18]. Our data show that
pretreatment with curcumin prevented the influx of inflammatory
cell in the BAL fluid, and the increase of airway resistance caused
by repeated exposure to DEP. Interestingly, the concentration of
TNFa in BAL returned to control level suggesting a pivotal role of
this proinflammatory cytokine in the observed respiratory levels.
Similarly, curcumin pretreatment suppressed the DEP-induced
elevation of TNFa and CRP in plasma confirming its potent
inflammatory effects. Earlier studies showed that curcumin inhibits
TNFa-dependent NFkB activation and blocks the TNF a
mediated downregulation of PPAR c in mesangial cells [53].
Besides inhibiting systemic inflammation, curcumin pretreatment
potently prevented the increase of SBP caused by repeated
exposure to DEP. Curcumin has been reported to prevent cardiac
hypertrophy in salt sensitive Dahl rats by exerting a beneficial
preservation of systolic function [54]. The same authors also
showed that the acetylation of GATA4 that normally accompanies
hypertension was reduced by curcumin [54].
Curcumin pretreatment prevented the increase of PAI-1 and D-
dimer concentrations in plasma, both of which play important
roles in coronary thrombosis and arteriosclerosis [47,48,55]. It has
been reported that TNFa is a strong agonist for PAI-1 expression
and has been found to play an important role in PAI-1 regulation
in a variety of diseases. In a mouse endoxemia model, TNFa has
been found to contribute to the lipopolysaccharide-induced PAI-1
expression [56]. In the obesity-associated elevation of PAI-1,
evidence also points to TNFa as an important regulator of PAI-1
expression in adipose tissue [55]. Likewise, in line with our results,
it has been shown that TNF-alpha, but not IL-6, stimulates PAI-1
expression in human subcutaneous adipose tissue [57,58]. Our
finding corroborates the recent study of Budinger et al. [29] which
demonstrated that ambient PM-induced upregulation of PAI-1,
disappeared upon treatment of mice with a TNFa inhibitor [29].
This confirms aupivotal role of TNFa in the observed effects. The
effect of curcumin on pial arteriolar thrombosis, a model that
depends mainly on platelet activation and aggregation [7], showed
a partial but significant inhibition. Likewise, the decrease of
platelet numbers caused by repeated exposure to DEP was
partially prevented by curcumin. The partial inhibition of
curcumin on DEP-induced thrombosis in pial arterioles and
decrease in circulating platelet numbers suggest that DEP also
exerts a direct effect on platelet aggregation. We and others have
previously showed that DEP cause platelet aggregation ex-vivo and
in vitro [6,8,59].
In conclusion, this work has shown that repeated exposure to
DEP induced airway inflammation and hyperreactivity, systemic
inflammation, increased SBP, and accelerated coagulation. TNF a
production was increased both in BAL and plasma. Pretreatment
with curcumin significantly inhibited the release of TNF a and
prevented the respiratory and cardiovascular effects. Further
studies using TNFa knockout mice are needed to confirm the
central role of TNFa in the observed cardiopulmonary effects.
Our findings indicate that curcumin is a potent anti-inflammatory
agent that protects against the cardiopulmonary effects of DEP.
Our data are in line with previous studies which reported the
beneficial anti-inflammatory effect of curcumin on lipopolysac-
charides-induced lung inflammation and edema [60], cigarette
smoke-induced pulmonary inflammation and emphysema [13] or
bleomycin-induced pulmonary fibrosis [12]. Our findings may
have therapeutic implications for the potential use of curcumin in
prevention of the pulmonary and cardiovascular effects of
pollutant particles.
Acknowledgments
The authors would like to thank Mrs. S. Zia for her technical help.
Author Contributions
Conceived and designed the experiments: AN BHA. Performed the
experiments: DS. Analyzed the data: AN DS. Contributed reagents/
materials/analysis tools: AN. Wrote the paper: AN BHA.
References
1. Franchini M, Mannucci PM (2011) Thrombogenicity and cardiovascular effects
of ambient air pollution. Blood 118: 2405–2412.
2. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, et al. (2010)
Particulate Matter Air Pollution and Cardiovascular Disease An Update to the
Scientific Statement From the American Heart Association. Circulation 121:
2331–2378.
3. Vermylen J, Nemmar A, Nemery B, Hoylaerts MF (2005) Ambient air pollution
and acute myocardial infarction. J Thromb Haemost 3: 1955–1961.
4. Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, et al. (2007)
Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with
coronary heart disease. N Engl J Med 357: 1075–1082.
5. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, et al. (2009)
Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med
6: 36–44.
6. Nemmar A, Hoet PH, Dinsdale D, Vermylen J, Hoylaerts MF, et al. (2003)
Diesel exhaust particles in lung acutely enhance experimental peripheral
thrombosis. Circulation 107: 1202-1208.
7. Nemmar A, Al Salam S, Dhanasekaran S, Sudhadevi M, Ali BH (2009)
Pulmonary exposure to diesel exhaust particles promotes cerebral microvessel
thrombosis: protective effect of a cysteine prodrug l-2-oxothiazolidine-4-
carboxylic acid. Toxicology 263: 84–92.
8. Nemmar A, Al-Salam S, Zia S, Marzouqi F, Al-Dhaheri A, et al. (2011)
Contrasting actions of diesel exhaust particles on the pulmonary and
cardiovascular systems and the effects of thymoquinone. Br J Pharmacol 164:
1871–1882.
9. Ali BH, Marrif H, Noureldayem SA, Bakheit AO, Blunden G (2006) Some
biological properties of curcumin: A review. Natural Product Communications
1: 509–521.
10. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC (2006) Multiple biological
activities of curcumin: a short review. Life Sci 78: 2081–2087.
11. Shishodia S, Potdar P, Gairola CG, Aggarwal BB (2003) Curcumin
(diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activa-
tion through inhibition of IkappaBalpha kinase in human lung epithelial cells:
correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis
24: 1269–1279.
12. Punithavathi D, Venkatesan N, Babu M (2000) Curcumin inhibition of
bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 131: 169–172.
13. Suzuki M, Betsuyaku T, Ito Y, Nagai K, Odajima N, et al. (2009) Curcumin
attenuates elastase- and cigarette smoke-induced pulmonary emphysema in
mice. Am J Physiol Lung Cell Mol Physiol 296: L614–L623.
14. Nemmar A, Al Maskari S, Ali BH, Al Amri IS (2007) Cardiovascular and lung
inflammatory effects induced by systemically administered diesel exhaust
particles in rats. Am J Physiol Lung Cell Mol Physiol 292: L664–L670.
Curcumin and Toxicity of Diesel Particles
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e3955415. Saber AT, Bornholdt J, Dybdahl M, Sharma AK, Loft S, et al. (2005) Tumor
necrosis factor is not required for particle-induced genotoxicity and pulmonary
inflammation. Arch Toxicol 79: 177–182. 10.1007/s00204-004-0613-9 [doi].
16. Ying Z, Yue P, Xu X, Zhong M, Sun Q, et al. (2009) Air pollution and cardiac
remodeling: a role for RhoA/Rho-kinase. Am J Physiol Heart Circ Physiol 296:
H1540–H1550.
17. Vanoirbeek JA, Tarkowski M, Ceuppens JL, Verbeken EK, Nemery B, et al.
(2004) Respiratory response to toluene diisocyanate depends on prior frequency
and concentration of dermal sensitization in mice. Toxicol Sci 80: 310–321.
18. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, et al. (2004)
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.
Science 304: 600–602. 10.1126/science.1093941 [doi];304/5670/600 [pii].
19. Mutlu GM, Green D, Bellmeyer A, Baker CM, Burgess Z, et al. (2007) Ambient
particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin
Invest 117: 2952–2961.
20. Brook RD, Franklin B, Cascio W, Hong YL, Howard G, et al. (2004) Air
pollution and cardiovascular disease-A statement for healthcare professionals
from the expert panel on population and prevention science of the American
Heart Association. Circulation 109: 2655–2671.
21. U.N.Environment Program and WHO Report (1994) Air Pollution in the
world’s megacities. A Report from the U.N. Environment Programme and
WHO. Environment 36: 5–37.
22. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, et al. (2000)
Intratracheal instillation as an exposure technique for the evaluation of
respiratory tract toxicity: uses and limitations. Toxicol Sci 55: 24–35.
23. Nemmar A, Hoet PHM, Vermylen J, Nemery B, Hoylaerts MF (2004)
Pharmacological stabilization of mast cells abrogates late thrombotic events
induced by diesel exhaust particles in hamsters. Circulation 110: 1670–1677.
24. Nemmar A, Melghit K, Ali BH (2008) The Acute Proinflammatory and
Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats.
Exp Biol Med (Maywood ) 233: 610–619.
25. Kido T, Tamagawa E, Bai N, Suda K, Yang HH, et al. (2010) Particulate
Matter Induces IL-6 Translocation from the Lung to the Systemic Circulation.
Am J Respir Cell Mol Biol.
26. Nemmar A, Al Salam S, Zia S, Yasin J, Al Husseni I, et al. (2010) Diesel Exhaust
Particles in the Lung Aggravate Experimental Acute Renal Failure. Toxicolog-
ical Sciences 113: 267–277.
27. Salvi S, Blomberg A, Rudell B, Kelly F, Sandstrom T, et al. (1999) Acute
inflammatory responses in the airways and peripheral blood after short-term
exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care
Med 159: 702–709.
28. Behndig AF, Mudway IS, Brown JL, Stenfors N, Helleday R, et al. (2006)
Airway antioxidant and inflammatory responses to diesel exhaust exposure in
healthy humans. Eur Respir J 27: 359–365.
29. Budinger GRS, Mckell JL, Urich D, Foiles N, Weiss I, et al. (2011) Particulate
Matter-Induced Lung Inflammation Increases Systemic Levels of PAI-1 and
Activates Coagulation Through Distinct Mechanisms. Plos One 6.
30. Delfino RJ, Staimer N, Tjoa T, Gillen DL, Polidori A, et al. (2009) Air Pollution
Exposures and Circulating Biomarkers of Effect in a Susceptible Population:
Clues to Potential Causal Component Mixtures and Mechanisms. Environ
Health Perspect 117: 1232–1238.
31. Brook RD, Urch B, Dvonch JT, Bard RL, Speck M, et al. (2009) Insights into
the mechanisms and mediators of the effects of air pollution exposure on blood
pressure and vascular function in healthy humans. Hypertension 54: 659–667.
32. Nemmar A, Al Salam S, Dhanasekaran S, Sudhadevi M, Ali BH (2009)
Pulmonary exposure to diesel exhaust particles promotes cerebral microvessel
thrombosis: Protective effect of a cysteine prodrug L-2-oxothiazolidine-4-
carboxylic acid. Toxicology 263: 84–92.
33. Nordenhall C, Pourazar J, Ledin MC, Levin JO, Sandstrom T, et al. (2001)
Diesel exhaust enhances airway responsiveness in asthmatic subjects. Eur
Respir J 17: 909–915.
34. Salam MT, Islam T, Gilliland FD (2008) Recent evidence for adverse effects of
residential proximity to traffic sources on asthma. Curr Opin Pulm Med 14: 3–8.
10.1097/MCP.0b013e3282f1987a [doi];00063198-200801000-00003 [pii].
35. Sallam N, Khazaei M, Laher I (2010) Effect of moderate-intensity exercise on
plasma C-reactive protein and aortic endothelial function in type 2 diabetic
mice. Mediators Inflamm 2010: 149678. 10.1155/2010/149678 [doi].
36. Park NY, Park SK, Lim Y (2011) Long-term dietary antioxidant cocktail
supplementation effectively reduces renal inflammation in diabetic mice. Br J
Nutr 106: 1514–1521. S0007114511001929 [pii];10.1017/S0007114511001929
[doi].
37. Packard RR, Libby P (2008) Inflammation in atherosclerosis: from vascular
biology to biomarker discovery and risk prediction. Clin Chem 54: 24–38.
38. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, et al. (2004) Inflammatory
markers and the risk of coronary heart disease in men and women. N Engl J
Med 351: 2599-2610. 351/25/2599 [pii];10.1056/NEJMoa040967 [doi].
39. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, et al. (2008) Circulating
biomarkers of inflammation, antioxidant activity, and platelet activation are
associated with primary combustion aerosols in subjects with coronary artery
disease. Environ Health Perspect 116: 898-906. 10.1289/ehp.11189 [doi].
40. Brook RD, Rajagopalan S (2009) Particulate matter, air pollution, and blood
pressure. J Am Soc Hypertens 3: 332–350. S1933-1711(09)00105-3
[pii];10.1016/j.jash.2009.08.005 [doi].
41. Sun Q, Hong X, Wold LE (2010) Cardiovascular effects of ambient particulate
air pollution exposure. Circulation 121: 2755–2765.
42. Ruckerl R, Phipps RP, Schneider A, Frampton M, Cyrys J, Oberdorster G,
Wichmann HE, Peters A (2007) Ultrafine particles and platelet activation in
patients with coronary heart disease-results from a prospective panel study. Part
Fibre Toxicol 4: 1.
43. Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating
the biology of atherosclerosis. Nature 473: 317-325. nature10146 [pii];10.1038/
nature10146 [doi].
44. Yeh ET (2004) CRP as a mediator of disease. Circulation 109: II11–II14.
10.1161/01.CIR.0000129507.12719.80 [doi];109/21_suppl_1/II-11 [pii].
45. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, et al. (1998)
High plasminogen activator inhibitor and tissue plasminogen activator levels in
plasma precede a first acute myocardial infarction in both men and women:
evidence for the fibrinolytic system as an independent primary risk factor.
Circulation 98: 2241–2247.
46. Cesari M, Pahor M, Incalzi RA (2010) Plasminogen activator inhibitor-1 (PAI-
1): a key factor linking fibrinolysis and age-related subclinical and clinical
conditions. Cardiovasc Ther 28: e72–e91. CDR171 [pii];10.1111/j.1755-
5922.2010.00171.x [doi].
47. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ (1994) Plasma
concentration of cross-linked fibrin degradation product (D-dimer) and the risk
of future myocardial infarction among apparently healthy men. Circulation 90:
2236–2240.
48. Lowe GD, Rumley A (1999) Use of fibrinogen and fibrin D-dimer in prediction
of arterial thrombotic events. Thromb Haemost 82: 667-672. 99080667 [pii].
49. Ruckerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, et al. (2006) Air
pollution and markers of inflammation and coagulation in patients with
coronary heart disease. Am J Respir Crit Care Med 173: 432–441.
50. Epstein JA (2008) Currying favor for the heart. J Clin Invest 118: 850–852.
10.1172/JCI34650 [doi].
51. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, et al. (2001) Phase I clinical trial
of curcumin, a chemopreventive agent, in patients with high-risk or pre-
malignant lesions. Anticancer Res 21: 2895–2900.
52. Su CC, Yang JS, Lu CC, Chiang JH, Wu CL, et al. (2010) Curcumin inhibits
human lung large cell carcinoma cancer tumour growth in a murine xenograft
model. Phytother Res 24: 189–192. 10.1002/ptr.2905 [doi].
53. Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, et al. (2009)
Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of
inflammation. Am J Physiol Renal Physiol 296: F1146-F1157. 90732.2008
[pii];10.1152/ajprenal.90732.2008 [doi].
54. Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, et al. (2008) The
dietary compound curcumin inhibits p300 histone acetyltransferase activity and
prevents heart failure in rats. J Clin Invest 118: 868-878. 10.1172/JCI33160
[doi].
55. Gruber F, Hufnagl P, Hofer-Warbinek R, Schmid JA, Breuss JM, et al. (2003)
Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-
1) promoter regulates TNF alpha-induced PAI-1 expression. Blood 101: 3042–
3048. 10.1182/blood-2002-07-2331 [doi];2002-07-2331 [pii].
56. Yamashita M, Yamashita M (1997) Tumor necrosis factor alpha is involved in
the induction of plasminogen activator inhibitor-1 by endotoxin. Thromb Res
87: 165–170. S0049-3848(97)00116-3 [pii].
57. Hou B, Eren M, Painter CA, Covington JW, Dixon JD, et al. (2004) Tumor
necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene
through a distal nuclear factor kappaB site. J Biol Chem 279: 18127–18136.
10.1074/jbc.M310438200 [doi]; M310438200 [pii].
58. Plomgaard P, Keller P, Keller C, Pedersen BK (2005) TNF-alpha, but not IL-6,
stimulates plasminogen activator inhibitor-1 expression in human subcutaneous
adipose tissue. J Appl Physiol 98: 2019–2023. 01220.2004 [pii];10.1152/
japplphysiol.01220.2004 [doi].
59. Nemmar A, Al Salam S, Zia S, Dhanasekaran S, Shudadevi M, et al. (2010)
Time-course effects of systemically administered diesel exhaust particles in rats.
Toxicol Lett. 194:58–65.
60. Suresh MV, Wagner MC, Rosania GR, Stringer KA, Min KA, et al. (2012)
Pulmonary Administration of Water-soluble Curcumin Complex Reduces ALI
Severity. Am J Respir Cell Mol Biol. rcmb.2011-0175OC [pii];10.1165/
rcmb.2011-0175OC [doi].
Curcumin and Toxicity of Diesel Particles
PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39554